Role of WNT16 in the regulation of periosteal bone formation in female mice

Endocrinology (United States)

Volumn 156, Issue 3, 2015, Pages 1023-1032

  Wergedal, Jon E ^a,b   Kesavan, Chandrasekhar ^a,b   Brommage, Robert ^c   Das, Subhashri ^a   Mohan, Subburaman ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; FRIZZLED PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT16 PROTEIN; RNA; WNT16 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; BONE DENSITOMETRY; BONE STRENGTH; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FLUID FLOW; GENE EXPRESSION; GENOTYPE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; PERIOSTEUM; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA ISOLATION; SHEAR STRESS; SURFACE PROPERTY; WILD TYPE; ANIMAL; BONE DENSITY; BONE DEVELOPMENT; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BONE DENSITY; BONE DEVELOPMENT; FEMALE; FRIZZLED RECEPTORS; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; PERIOSTEUM; RNA; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84923872502     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1702     Document Type: Article

References (43)

1. Zheng HF, Tobias JH, Duncan E, et al. WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet. 2012:8:e1002745.
2. Koller DL, Zheng HF, Karasik D, et al. Meta-analysis of genomewide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women. J Bone Miner Res. 2013;28:547-558.
3. García-Ibarbia C, Pérez-Núñez MI, Olmos JM, et al. Missense polymorphisms of the WNT16 gene are associated with bone mass, hip geometry and fractures. Osteoporos Int. 2013;24:2449-2454.
4. Hendrickx G, Boudin E, Fijalkowski I, et al. Variation in the Kozak sequence of WNT16 results in an increased translation and is associated with osteoporosis related parameters. Bone. 2014;59:57-65.
5. Zhang L, Choi HJ, Estrada K, et al. Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum Mol Genet. 2014;23:1923-1933.
6. Estrada K, Styrkarsdottir U, Evangelou E, et al. Genome-wide metaanalysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. 2012;44:491-501.
7. Medina-Gomez C, Kemp JP, Estrada K, et al. Meta-analysis of genome-wide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locus. PLoS Genet. 2012;8:e1002718.
8. Tu X, Rhee Y, Condon KW, et al. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone. 2012;50:209-217.
9. Liedert A, Wagner L, Seefried L, Ebert R, Jakob F, Ignatius A. Estrogen receptor and Wnt signaling interact to regulate early gene expression in response to mechanical strain in osteoblastic cells. Biochem Biophys Res Commun. 2010;394:755-759.
10. Santos A, Bakker AD, Zandieh-Doulabi B, Semeins CM, Klein-Nulend J. Pulsating fluid flow modulates gene expression of proteins involved in Wnt signaling pathways in osteocytes. J Orthop Res. 2009;27:1280-1287.
11. Case N, Ma M, Sen B, Xie Z, Gross TS, Rubin J. β-Catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem. 2008;283:29196-29205.
12. Armstrong VJ, Muzylak M,Sunters A, et al. Wnt/β-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor α. J Biol Chem. 2007;282:20715-20727.
13. Clements WK, Kim AD, Ong KG, Moore JC, Lawson ND, Traver D. A somitic Wnt16/Notch pathway specifies haematopoietic stem cells. Nature. 2011;474:220-224.
14. Mazieres J, You L, He B, et al. Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene. 2005;24:5396-5400.
15. Teh MT, Blaydon D, Ghali LR, et al. Role for WNT16B in human epidermal keratinocyte proliferation and differentiation. J Cell Sci. 2007;120:330-339.
16. Brommage R, Liu J, Hansen GM, et al. High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes. Bone Res. 2014;2:14034.
17. Govoni KE, Wergedal JE, Florin L, Angel P, Baylink DJ, Mohan S. Conditional deletion of insulin-like growth factor-I in collagen type 1α2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion. Endocrinology. 2007;148:5706-5715.
18. Sengul A, Santisuk R, Xing W, Kesavan C. Systemic administration of an antagomir designed to inhibit miR-92, a regulator of angiogenesis, failed to modulate skeletal anabolic response to mechanical loading. Physiol Res. 2013;62:221-226.
19. Kapur S,Mohan S, Baylink DJ, Lau KH. Fluid shear stress synergizes with insulin-like growth factor-I (IGF-I) on osteoblast proliferation through integrin-dependent activation of IGF-I mitogenic signaling pathway. J Biol Chem. 2005;280:20163-20170.
20. Kesavan C, Mohan S, Oberholtzer S, Wergedal JE, Baylink DJ. Mechanical loading-induced gene expression and BMD changes are different in two inbred mouse strains. J Appl Physiol. 2005;99:1951-1957.
21. Lau KH, Baylink DJ, Zhou XD, et al. Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity. Am J Physiol Endocrinol Metab. 2013;305:E271-E281.
22. Kesavan C, Wergedal JE, Lau KH, Mohan S. Conditional disruption of IGF-I gene in type 1α collagen-expressing cells shows an essential role of IGF-I in skeletal anabolic response to loading. Am J Physiol Endocrinol Metab. 2011;301:E1191-E1197.
23. Sheng MH, Baylink DJ, Beamer WG, et al. Histomorphometric studies show that bone formation and bone mineral apposition rates are greater in C3H/HeJ (high-density) than C57BL/6J (low-density) mice during growth. Bone. 1999;25:421-429.
24. Moverare-Skrtic S, Henning P, Rjesson BA, et al. Wnt16 is a novel osteoblast-derived paracrine regulator of osteoclastogenesis, cortical bone mass and fracture susceptibility. J Bone Miner Res. 2013;28(Suppl 1):S39.
25. Liu X, Nagano K, Saito H, Baron R, Gori F. Wnt16 deletion differentially affects cortical and trabecular bone: increased cortical bone resorption, porosity and fracture in Wnt16 knockout mice. J Bone Miner Res. 2013;28(Suppl 1):S20.
26. Turner CH, Hsieh YF, Müller R, et al. Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res. 2000;15:1126-1131.
27. Gao Y, Huang E, Zhang H, et al. Crosstalk between Wnt/beta-catenin and estrogen receptor signaling synergistically promotes osteogenic differentiation of mesenchymal progenitor cells. PLoS One. 2013;8:e82436.
28. Gupta N, Schmitt F, Grebhardt S, Mayer D. β-Catenin is a positive regulator of estrogen receptor-α function in breast cancer cells. Cancers (Basel). 2011;3:2990-3001.
29. Auld KL, Berasi SP, Liu Y, et al. Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signaling. J Mol Endocrinol. 2012;48:177-191.
30. Kawanami A, Matsushita T, Chan YY, Murakami S. Mice expressing GFP and CreER in osteochondro progenitor cells in the periosteum. Biochem Biophys Res Commun. 2009;386:477-482.
31. Bonnet N, Conway SJ, Ferrari SL. Regulation of β catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Proc Natl Acad Sci USA. 2012;109:15048-15053.
32. Cao Y, Zhou Z, de Crombrugghe B, et al. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma. Cancer Res. 2005;65:1124-1128.
33. Yamashita T, Nabeshima Y, Noda M. High-resolution micro-computed tomography analyses of the abnormal trabecular bone structures in klotho gene mutant mice. J Endocrinol. 2000;164:239-245.
34. Hamrick MW, Pennington C, Newton D, Xie D, Isales C. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone. 2004;34:376-383.
35. Brommage R, Liu J, Lee EC. Elevated trabecular bone mass with reduced cortical bone thickness in sFRP4 knockout mice. J Bone Miner Res. 2009;24(Suppl 1):S82.
36. Chen J, Tu X, Esen E, et al. WNT7B promotes bone formation in part through mTORC1. PLoS Genet. 2014;10:e1004145.
37. Albers J, Schulze J, Beil FT, et al. Control of bone formation by the serpentine receptor Frizzled-9. J Cell Biol. 2011;192:1057-1072.
38. Holmen SL, Giambernardi TA, Zylstra CR, et al. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res. 2004;19:2033-2040.
39. Li X, Ominsky MS, Niu QT, et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008;23:860-869.
40. Rossini M, Gatti D, Adami S. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int. 2013;93:121-132.
41. McGee-Lawrence ME, Li X, Bledsoe KL, et al. Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice. J Biol Chem. 2013;288:5291-5302.
42. Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res. 2007;13:4042-4045.
43. Chen Y, Whetstone HC, Lin AC, et al. β-Catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med. 2007;4:e249.